About this item:
819 Views | 433 Downloads
Author Notes:
Email Address: praggi@emory.edu
Subjects:
Research Funding:
Dr. E. Rojas is supported by a training grant from Genzyme Therapeutics
Dr. Paolo Raggi has received research grants from and he is part of a Medical Advisory Board for Genzyme Therapeutics.
Lack of correction of secondary hyperparathyroidism long term after kidney transplantation despite good graft function
Abstract:
Secondary hyperparathyroidism (SHPT) and its associated bone and vascular complications are highly prevalent in patients undergoing renal replacement therapy. Whether successful kidney transplantation corrects SHPT in the majority of patients with a functioning graft is unclear. In the context of an ongoing, randomized study on the effects of vitamin D therapy in post-transplant patients, we reviewed the clinical data of 150 consecutive kidney or kidney–pancreas transplant recipients with a functioning graft a minimum of 1 year after transplantation at our institution.
Copyright information:
© The Author [2008].
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/by-nc/4.0/), which permits distribution of derivative works, distribution, public display, and publicly performance, making multiple copies, provided the original work is properly cited. This license requires copyright and license notices be kept intact, credit be given to copyright holder and/or author. This license prohibits exercising rights for commercial purposes.
